Wave 3 of the UK Government’s science and innovation audits (SIAs) have been published today, identifying a number of strengths in different industries across the country — including precision medicine innovation in Scotland, led by the University of Glasgow.
The report highlights REPROCELL’s recent work in the field of precision medicine, in collaboration with Stratified Medicines Scotland and SMEs throughout Scotland, combining the ability to access human fresh tissues with clinical data, pharmacology and ‘omics’.
This research offers the promise of helping patients to receive the most effective available medication and will help drug companies to evaluate precision medicine strategies at an early stage of drug development.